Steward Partners Investment Advisory’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-100
Closed -$2.96K 3707
2023
Q4
$2.96K Hold
100
﹤0.01% 3132
2023
Q3
$1.59K Hold
100
﹤0.01% 3117
2023
Q2
$1.89K Hold
100
﹤0.01% 3032
2023
Q1
$384 Hold
100
﹤0.01% 3188
2022
Q4
$496 Sell
100
-18
-15% -$98 ﹤0.01% 3195
2022
Q3
$1K Sell
118
-21
-15% -$111 ﹤0.01% 3192
2022
Q2
$1K Hold
139
﹤0.01% 3201
2022
Q1
$1K Buy
139
+39
+39% +$216 ﹤0.01% 3245
2021
Q4
$1K Hold
100
﹤0.01% 3146
2021
Q3
$1K Hold
100
﹤0.01% 3118
2021
Q2
$1K Sell
100
-3,575
-97% -$24.9K ﹤0.01% 7006
2021
Q1
$29.8K Buy
3,675
+3,100
+539% +$25.3K ﹤0.01% 2270
2020
Q4
$4K Sell
575
-35
-6% -$204 ﹤0.01% 2597
2020
Q3
$2K Sell
610
-60
-9% -$242 ﹤0.01% 2617
2020
Q2
$3K Hold
670
﹤0.01% 2439
2020
Q1
$2K Hold
670
﹤0.01% 2337
2019
Q4
$3K Hold
670
﹤0.01% 2390
2019
Q3
$1K Sell
670
-361
-35% -$958 ﹤0.01% 2570
2019
Q2
$2K Buy
+1,031
New +$2.44K ﹤0.01% 2480
2018
Q4
Sell
-1,500
Closed -$14K 2292
2018
Q3
$14K Buy
1,500
+308
+26% +$2.96K ﹤0.01% 1740
2018
Q2
$12K Buy
1,192
+631
+112% +$6.65K ﹤0.01% 1680
2018
Q1
$5K Buy
561
+65
+13% +$642 ﹤0.01% 1820
2017
Q4
$3K Buy
496
+108
+28% +$666 ﹤0.01% 1663
2017
Q3
$2K Hold
388
﹤0.01% 1542
2017
Q2
$2K Buy
388
+208
+116% +$952 ﹤0.01% 1460
2017
Q1
$0 Hold
180
﹤0.01% 1583
2016
Q4
$0 Buy
+180
New +$361 ﹤0.01% 903

Other funds holding IMGN

Steward Partners Investment Advisory's IMGN Position: Q1 2024 in Review

Steward Partners Investment Advisory sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 100 shares — an estimated $2.96K sold.

Steward Partners Investment Advisory first reported a position in IMGN in Q4 2016 and held it in 27 quarters. The position peaked at $29.8K in Q1 2021. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Steward Partners Investment Advisory reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 100 Immunogen Inc shares in Q1 2024, an estimated $2.96K.
  • Steward Partners Investment Advisory first reported a position in Immunogen Inc in Q4 2016 and held it in 27 quarters.
  • Steward Partners Investment Advisory's Immunogen Inc position peaked at $29.8K in Q1 2021.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2024, filed 15 May 2024.